T-cell lymphoma as a model for the use of histone deacetylase inhibitors in cancer therapy: impact of depsipeptide on molecular markers, therapeutic targets, and mechanisms of resistance (Q40583269)
Jump to navigation
Jump to search
scientific article published on 2 March 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | T-cell lymphoma as a model for the use of histone deacetylase inhibitors in cancer therapy: impact of depsipeptide on molecular markers, therapeutic targets, and mechanisms of resistance |
scientific article published on 2 March 2004 |
Statements
1 reference
T-cell lymphoma as a model for the use of histone deacetylase inhibitors in cancer therapy: impact of depsipeptide on molecular markers, therapeutic targets, and mechanisms of resistance (English)
1 reference
Robert W Robey
1 reference
Susan E Bates
1 reference
Richard L Piekarz
1 reference
Zhirong Zhan
1 reference
Ganesh Kayastha
1 reference
Anousheh Sayah
1 reference
Amina H Abdeldaim
1 reference
Sonia Torrico
1 reference
2 March 2004
1 reference
Identifiers
1 reference